 |
FDA Approval Activities for this Drug
VFEND (voriconazole) Tablets & Powder for Injection, 50& 200 mg and 200 mg, respectively, Pfizer, NDA 21-266/S-002 & 21-267/S-003 3/28/03 4/14/03 4/1/03
VFEND (voriconazole) Tablets & VFEND (voriconazole for infusion), Pfizer NDA 21-266 & 21-267 VFEND (voriconazole) Tablets & Injection, Pfizer | VFEND (voriconazole) Tablets, Pfizer, Inc., New or Modified Indication
| VFEND I.V. (voriconazole) for Injection, Pfizer, Inc., New or Modified Indication
| VFEND (voriconazole) for Oral Suspension,, Pfizer, Inc., New or Modified Indication | VFEND (voriconazole) Tablets, Pfizer, Labeling Revision | VFEND I.V. (voriconazole) Injection, Pfizer, Labeling Revision | VFEND (voriconazole) Oral Suspension, Pfizer, Labeling Revision
For the most up-to-date approval information, please locate this API using the drug index.
|